VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway

被引：0
作者：
Zhangya Pu
Dan G. Duda
Yuanyuan Zhu
Siya Pei
Xiaofang Wang
Yan Huang
Panpan Yi
Zebing Huang
Fang Peng
Xingwang Hu
Xuegong Fan
机构：
[1] Central South University,Department of Infectious Diseases, Hunan Key Laboratory of Viral Hepatitis, Xiangya Hospital
[2] Central South University,NHC Key Laboratory of Cancer Proteomics, Xiangya Hospital
[3] Massachusetts General Hospital,E.L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology
来源：
Journal of Translational Medicine | / 20卷
关键词：
Hepatocellular carcinoma; VCP; HMGB1; PI3K/AKT/mTOR pathway; Tumor progression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[21]   ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway [J].
Han Chen ;
Hengxiao Wang ;
Xiqiao Yu ;
Shuping Zhou ;
Yueying Zhang ;
Zhaopeng Wang ;
Shuhong Huang ;
Zhaoxia Wang .
BMC Cancer, 20
[22]   MiR-660-5p promotes the progression of hepatocellular carcinoma by interaction with YWHAH via PI3K/Akt signaling pathway [J].
Wu, Yunyu ;
Zhang, Yan ;
Wang, Feng ;
Ni, Qingfeng ;
Li, Mei .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 531 (04) :480-489
[23]   Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma [J].
Bang, Jieun ;
Jun, Mihyeon ;
Lee, Soyun ;
Moon, Hyuk ;
Ro, Simon Weonsang .
PHARMACEUTICS, 2023, 15 (08)
[24]   Ruscogenin suppressed the hepatocellular carcinoma metastasis via PI3K/Akt/mTOR signaling pathway [J].
Hua, Hui ;
Zhu, Yu ;
Song, Yu-He .
BIOMEDICINE & PHARMACOTHERAPY, 2018, 101 :115-122
[25]   Digoxigenin activates autophagy in hepatocellular carcinoma cells by regulating the PI3K/AKT/mTOR pathway [J].
Ma, Mengqing ;
Hu, Rui ;
Huang, Qi ;
Li, Jing ;
Lv, Minling ;
Sun, Jialing ;
Zhong, Xin ;
Yi, Jinyu ;
Peng, Lanfen ;
Feng, Wenxing ;
Ma, Wenfeng ;
Han, Zhiyi ;
Zhang, Wei ;
Sun, Xinfeng ;
Zhan, Bolin ;
Liu, Xingning ;
Zhou, Xiaozhou .
CANCER CELL INTERNATIONAL, 2024, 24 (01)
[26]   Inhibition of NET-1 suppresses proliferation and promotes apoptosis of hepatocellular carcinoma cells by activating the PI3K/AKT signaling pathway [J].
Sun, Xiangjun ;
Wang, Mingchun ;
Zhang, Fenghua ;
Kong, Xiao .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (03) :2334-2340
[27]   Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma [J].
Shao, Weilin ;
Feng, Yan ;
Huang, Jin ;
Li, Tingyu ;
Gao, Shengguai ;
Yang, Yihao ;
Li, Dongqi ;
Yang, Zuozhang ;
Yao, Zhihong .
OPEN LIFE SCIENCES, 2024, 19 (01)
[28]   Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma [J].
Wang, Houhong ;
Chen, Wenli ;
Cui, Yayun ;
Gong, Huihui ;
Tang, Amao .
AGING-US, 2023, 15 (15) :7831-7843
[29]   E2F1-mediated GINS2 transcriptional activation promotes tumor progression through PI3K/AKT/mTOR pathway in hepatocellular carcinoma [J].
Zhang, Yao ;
Hao, Xiaopei ;
Han, Guoyong ;
Lu, Yiwei ;
Chen, Zhiqiang ;
Zhang, Long ;
Wu, Jindao ;
Wang, Xuehao .
AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (04) :1707-+
[30]   MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway [J].
Fu, Xiao ;
Wen, Hongqing ;
Jing, Li ;
Yang, Yujuan ;
Wang, Wenjuan ;
Liang, Xuan ;
Nan, Kejun ;
Yao, Yu ;
Tian, Tao .
CANCER SCIENCE, 2017, 108 (04) :620-631
12345